Testing Robotic Hip and Ankle Exoskeletons to Help Walking After Stroke
Tests powered hip and ankle exoskeletons in adults recovering from stroke with walking difficulty.
Plain-language title generated from the registry record
Registry title: Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
Key facts
- Where
- Atlanta, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06064604, who can take part
Where in United States
- Exoskeleton and Prosthetic Intelligent Controls LabAtlanta, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Georgia Institute of Technology
- Trial code
- NCT06064604
- Record updated
- 26 November 2025
- Original description
An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are controlled by an onboard computer that determines the timing and magnitude of assistance deployed to the user. Exoskeleton controller performance is key to providing beneficial assistance that does not inhibit the user's movement. Preceding work will compare the benefit of personalized hip versus ankle joint exoskeleton assistance for improvement of post-stroke gait. It will combine exoskeleton technology with the user's movement feedback to improve wearable robotic assistance to an individual stroke survivor's gait pattern. For the clinical trial research covered under this protocol, the investigator will test various exoskeleton technologies with stroke survivors in real-world contexts, indoors and outdoors, and measure clinically meaningful outcomes and user perceptions regarding technology usability and adoption. The long-term goal is to deploy self-adaptive, adoptable exoskeletons for personalized assistance during community ambulation.Read full original descriptionShow less
Clinical Trial: Powered Hip & Ankle Exoskeletons for Stroke Survivors With Gait Impairment
An exoskeleton device is a robotic system designed to improve an individual's ability to move and perform tasks encountered in everyday situations. These devices consist of external rigid limb segments that assists humans through different body movements with the use of actuators. These devices are controlled by an onboard computer that determines the timing and magnitude of assistance deployed to the user. Exoskeleton controller performance is key to providing beneficial assistance that does not inhibit the user's movement. Preceding work will compare the benefit of personalized hip versus ankle joint exoskeleton assistance for improvement of post-stroke gait. It will combine exoskeleton technology with the user's movement feedback to improve wearable robotic assistance to an individual stroke survivor's gait pattern. For the clinical trial research covered under this protocol, the investigator will test various exoskeleton technologies with stroke survivors in real-world contexts, indoors and outdoors, and measure clinically meaningful outcomes and user perceptions regarding technology usability and adoption. The long-term goal is to deploy self-adaptive, adoptable exoskeletons for personalized assistance during community ambulation.
Inclusion: Between 18-85 years of age; Stroke at least 6 months prior to study involvement; Community dwelling (participant does not live in an assisted living facility); Able to provide informed consent to participate in the study activities; Can safely participate in the study activities (per self-report); Must have a Functional Ambulation Category (FAC) score of 3 or above (the participant can walk without the assistance of another person).
Exclusion: Has a significant secondary deficit beyond stroke (e.g. amputation, legal blindness or other severe impairment or condition) that in the opinion of the Principal Investigator (PI), would likely affect the study outcome or confound the results; Requires a walker to walk independently; Has a shuffling gait pattern overground; Has a Functional Ambulation Category (FAC) score of 2 or lower (the participant requires the assistance of another person in order to walk); For exoskeleton-only studies, the exoskeleton device does not fit appropriately or safely, as determined by the research team during the fitting assessment.